Question 1

What is COFEPRIS and why is it important for medical device companies?

Accepted Answer

COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is the Mexican Federal Commission for Protection against Sanitary Risk, Mexico's health regulatory agency equivalent to the FDA. It regulates medical devices, IVDs, pharmaceuticals, and other health products in Mexico's growing medical device market. All medical device companies must obtain COFEPRIS approval and maintain compliance with NOM regulations to sell products in Mexico.

Question 2

What are the most important NOM regulations for medical devices?

Accepted Answer

Key NOM (Norma Oficial Mexicana) regulations include: NOM-241-SSA1-2021 for Good Manufacturing Practices (GMP), NOM-137-SSA1-2024 for medical device labeling requirements, and various product-specific NOMs. This page tracks all major NOM updates and COFEPRIS regulatory changes from premium regulatory intelligence sources.

Question 3

What is the COFEPRIS Equivalency Route (Abbreviated Regulatory Pathway)?

Accepted Answer

The Equivalency Route, also known as the Abbreviated Regulatory Pathway, allows manufacturers to obtain expedited marketing authorization in Mexico based on prior approvals from recognized regulatory authorities (FDA, EMA/CE Mark, Health Canada, Swissmedic, ANVISA, TGA, MFDS, NMPA). Effective September 1, 2025, COFEPRIS expanded eligibility criteria and shortened review timelines to 30 business days for complete applications.

Question 4

How often does COFEPRIS publish new regulations and updates?

Accepted Answer

COFEPRIS publishes NOMs and regulatory updates regularly throughout the year. In 2025, major updates include the August 22 simplification agreement (effective October 6), new abbreviated pathway criteria (effective September 1), and revised NOM-137 labeling standards. This page aggregates COFEPRIS news from 7 premium commercial sources to provide daily updates on all regulatory changes and enforcement actions.

Question 5

What is a Mexico Registration Holder (MRH) and do I need one?

Accepted Answer

A Mexico Registration Holder (MRH), also called an Authorized Representative, is a legal entity based in Mexico required for foreign medical device manufacturers. The MRH acts on behalf of the manufacturer in all regulatory interactions with COFEPRIS, including registration, post-market surveillance, and compliance activities. All foreign companies must appoint an MRH to register and sell medical devices in Mexico. Learn more in our MRH selection guide.

Question 6

How can I stay updated on COFEPRIS regulatory changes?

Accepted Answer

This page automatically aggregates COFEPRIS and Mexico medical device news from 7 premium regulatory intelligence sources daily, including RAPS, Pacific Bridge Medical, Emergo by UL, and others. For comprehensive Mexico regulatory guidance, visit our NOM-241 GMP FAQ and NOM-137 Labeling FAQ. Pure Global provides comprehensive regulatory support for Mexico market access.

Question 7

What sources does this COFEPRIS news page aggregate from?

Accepted Answer

We aggregate Mexico and COFEPRIS news from 7 premium commercial regulatory intelligence sources: RAPS (Regulatory Affairs Professionals Society), Pacific Bridge Medical, Emergo by UL, Asia Actual, Citeline MedTech Insight, Pure Global's proprietary Mexico research team, and Qualtechs. All sources are filtered to show only Mexico-related regulatory updates using advanced keyword matching including COFEPRIS, NOM regulations, and Mexico-specific terminology.

COFEPRIS News & Mexico Medical Device Regulatory Updates 2025

Frequently Asked Questions About COFEPRIS News